Laman Utama600664 • SHA
add
Harbin Pharmaceutical Group Co., Ltd.
Tutup sebelumnya
¥3.81
Julat hari
¥3.79 - ¥3.87
Julat tahun
¥2.41 - ¥4.26
Permodalan pasaran
9.52B CNY
Bilangan Purata
47.50J
Nisbah P/E
15.92
Hasil dividen
-
Pertukaran utama
SHA
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (CNY) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 4.11B | 8.54% |
Perbelanjaan pengendalian | 833.10J | 0.85% |
Pendapatan bersih | 164.90J | 52.98% |
Margin untung bersih | 4.01 | 41.20% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 318.87J | 26.26% |
Kadar cukai berkesan | 23.46% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (CNY) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 3.13B | 13.03% |
Jumlah aset | 14.27B | 2.51% |
Jumlah liabiliti | 8.32B | -3.45% |
Jumlah ekuiti | 5.95B | — |
Syer tertunggak | 2.52B | — |
Harga kepada buku | 1.84 | — |
Pulangan pada aset | 4.51% | — |
Pulangan pada modal | 8.25% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (CNY) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 164.90J | 52.98% |
Tunai daripada operasi | 105.03J | -61.67% |
Tunai daripada pelaburan | -35.33J | 74.29% |
Tunai daripada pembiayaan | -173.45J | -5,358.43% |
Perubahan bersih dalam tunai | -104.01J | -174.49% |
Aliran tunai bebas | -77.99J | 22.01% |
Perihal
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Diasaskan
1988
Tapak web
Pekerja
9,853
